Venom peptides as pharmacological tools and therapeutics for diabetes
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 127, 79-86
Abstract
No abstract availableKeywords
Funding Information
- Margolis Foundation
- Utah Diabetes and Metabolism Center
- Juvenile Diabetes Research Foundation
This publication has 76 references indexed in Scilit:
- Computational Studies of Venom Peptides Targeting Potassium ChannelsToxins, 2015
- ATP-dependent potassium channels and type 2 diabetes mellitusClinical Biochemistry, 2015
- Voltage-Gated Ion Channels in Human Pancreatic β-Cells: Electrophysiological Characterization and Role in Insulin SecretionDiabetes, 2008
- Insulin Secretagogues, Sulfonylurea Receptors and KATP ChannelsCurrent Pharmaceutical Design, 2005
- Conkunitzin-S1 Is the First Member of a New Kunitz-type Neurotoxin FamilyJournal of Biological Chemistry, 2005
- Glucose Metabolism and Regulation: Beyond Insulin and GlucagonDiabetes Spectrum, 2004
- Crystal structure of desheptapeptide(B24–B30)insulin at 1.6 Å resolution: Implications for receptor bindingProceedings of the National Academy of Sciences, 1997
- Expression of Neuronal Traits in Pancreatic Beta CellsJournal of Biological Chemistry, 1997
- Electrophysiology of the pancreatic β-cellProgress in Biophysics and Molecular Biology, 1989
- Structure of Rhombohedral 2 Zinc Insulin CrystalsNature, 1969